MAKE SURE YOUR DENTIST IS AN ADA MEMBER!: ADA Members Adhere to Strict Code of Ethics and Conduct. You should make sure you are SEEING AN ADA MEMBER DENTIST! Visit ADA Find-A-Dentist to Find One Near YOU
Ninth District Headquarters Office - Hawthorne, NY

2025 Ninth District President

Dr. Renuka Bijoor

ADA Update: a new login experience

We’re updating how you log in to your NYSDA and ADA account.

RENEW YOUR MEMBERSHIP TODAY!

3 EASY WAYS TO PAY 1 ONLINE: nysdental.org/renew 2 MAIL: Return dues stub and payment 3 PHONE: 1-800-255-2100

Member Assistance Program (MAP)

Life comes with challenges, but your new Member Assistance Program (MAP) is here to help. This free, confidential benefit is available to you and your household, offering resources and services to support mental health, reduce stress, and make life easier.

Welcome to the Ninth District Dental Association

The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.

In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.

The mission of the 9th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.



Don't Forget to Register!! OPEN TO ALL MEMBERS!

9th District Social Event
Celebrating Frills & Drills

Wednesday, June 4, 2025

6:30-9:00 pm

ST. ANDREWS GOLF CLUB
10 Old Jackson Avenue
Hastings-on-Hudson, NY 10706

There will be a buffet, passed hors d'oeuvres, beer & wine, a cash bar, vendors, and lots of fun FOR ALL MEMBERS!

And a Keynote Lecture:  Leadership, High Performance & Mindset Mastery for the Female Clinician.
In this transformative session, Allison Lacoursiere explores the integration of feminine and masculine energies in leadership, revealing how balancing these forces unlocks extraordinary performance and sustainable success.  Through an engaging examination of neuroscience-based communication techniques and actionable insights into personal leadership, participants will learn to harness their unique strengths, elevate their professional presence, and master the mindset needed to thrive both clinically and personally.

Ms. Allison Lacoursiere is a certified, professional coach, high-performance expert, and transformational speaker dedicated to empowering clinicians and leaders.  With a dynamic blend of neuroscience-backed strategies, feminine and masculine energy principles, and powerful communication frameworks, Allison guides dental professionals toward unprecedented personal and professional growth.

Co-Sponsors

Bank of America, Practice Solutions

Danziger & Markhoff LLP*

DDSMatch


MLMIC Insurance Company*

We hope to see you there!

Renuka Bijoor, D.D.S., M.P.H.
President & Chair, Frills & Drills Subcommittee


 


Latest News Around the Tripartite

FDA Issues Digital Health Newsletter

Oct 30, 2024

The United States Food and Drug Administration (FDA) has issued its digital health newsletter, which can be read below.

FDA, Center for Devices and Radiological Health, Digital Health Newsletter


October 29, 2024

Welcome to the fall edition of the Digital Health Center of Excellence Newsletter. Learn about the latest digital health advancements to protect and promote public health.

Message from the DHCoE Director


With much anticipation, I am pleased the FDA will host the inaugural Digital Health Advisory Committee meeting on November 20-21, 2024, in Gaithersburg, Maryland, and virtually. Please join us for this public meeting.  

The advisory committee will discuss—

  • total product lifecycle considerations for generative artificial intelligence (AI)-enabled medical devices;
  • how the use of generative AI-may impact safety and effectiveness of medical devices enabled with this technology; and
  • premarket performance evaluation, risk management, and postmarket performance monitoring for generative AI-enabled devices.

Opportunities to participate in this meeting include contributing written comments through the public docket before November 1, 2024, or by providing an open public comment during the meeting.

Troy Tazbaz, Director, Digital Health Center of Excellence (DHCoE), Center for Devices and Radiological Health, U.S. Food and Drug Administration

Visit the advisory committee webpage for more information about the meeting.

New Activities and Resources

Open Public Docket: FDA Digital Health Advisory Committee Meeting in November

TPLC for Generative AI-enabled Devices, November 20-21, 2024The FDA established a docket for public comment on the inaugural Digital Health Advisory Committee meeting to be held November 20-21, 2024, in Gaithersburg, Maryland. Interested persons may present data, information, or views orally or in writing, on issues pending before the advisory committee. Comments received on or before November 1, 2024, will be provided to the advisory committee. For more information about submitting comments, please see the Federal Register Notice. The docket will close on January 21, 2025.

New Educational Resource: Digital Health and Artificial Intelligence Glossary

Digital representation of a brainThe FDA published a digital health and artificial intelligence glossary as an educational resource to help support consistent use of digital health and artificial intelligence terminology by the FDA and interested parties (such as industry, digital health developers, academia, health care professionals, and patients). The FDA plans to update the glossary as needed.

FDA List Updates: Medical Devices that Incorporate AR/VR or AI/ML

A person typing on a laptopOn September 6, 2024, the FDA updated the list of medical devices that incorporate augmented reality (AR) and virtual reality (VR). With this update, the FDA has authorized 69 medical devices that incorporate AR/VR. View the list.
On August 7, 2024, the FDA updated the list of artificial intelligence and machine learning (AI/ML)-enabled medical devices. With this update, the FDA has authorized 950 AI/ML-enabled medical devices. View the list.

Resource to Support Safe and Effective Innovation


Digital Health Policy NavigatorHave you used the Digital Health Policy Navigator? The FDA released this user-friendly tool to help developers determine whether their product's software functions are potentially the focus of the FDA's regulatory oversight. The Navigator walks you through seven steps, each with a set of questions to answer for each of your product's software functions. Your answers to these questions will help guide you through the most relevant FDA medical device regulatory considerations.

Recent Journal Publication

FDA Perspective on the Regulation of Artificial Intelligence in Healthcare and Biomedicine

A new JAMA article, published on October 14, 2024, describes the FDA’s central role in ensuring safe, effective, and trustworthy AI tools. The authors include Haider Warraich, MD, Senior Clinical Advisor, Office of the Commissioner; Troy Tazbaz, Director, Digital Health Center of Excellence, CDRH; and Robert Califf, MD, Commissioner of Food and Drugs, FDA.

We Are Hiring!

Scientists working in a labThe Digital Health Center of Excellence is continuing to build a dynamic team that is at the forefront of advancing medical science, creating new opportunities, and providing a regulatory environment that brings safe and effective digital health technologies to market.  We are seeking candidates for multiple positions with a variety of experiences in AI, generative AI, and data science to serve as digital health specialists. Our innovative thinking and patient-centric digital health specialists assist CDRH and the FDA in developing new and enhancing existing strategies and regulatory policies focused on digital health technologies. Our digital health specialists develop and utilize methodologies and protocols to assess the quality, predictability, and performance of digital health technologies, such as medical devices with AI technologies, wearables, patient monitoring devices, and sensor-based digital health technologies.
The deadline for applications is November 20, 2024. For more information about the positions and to apply, visit:

Contact Us

We value your feedback. Check out our Digital Health Frequently Asked Questions (FAQs). If you have additional questions, please e-mail us at DigitalHealth@fda.hhs.gov. DHCoE is leading the advancement of digital health to protect and promote public health. Visit our pages on FDA.gov to learn more about digital health products and regulatory policies. DHCoE’s newsletters are also available online.


Latest News Around the Ninth


Around the Ninth District